SPY ETF Analysis And how to play SPY ETF will do after inflation

Novartis ends development of KRAS drug, citing ‘increasing options available’

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

May 31, 2024

AI-Guidance Boosts Arrhythmia Ablation Success in Persistent Cases

BOSTON — For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after

May 19, 2024

European regulators recommend Novavax’s updated Covid vaccine

The European Medicines Agency’s human medicines committee (CHMP) today recommended Novavax’s adapted Nuvaxovid booster vaccine for preventing the Omicron XBB.1.5 subvariant of the coronavirus in

November 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.